Is CTIC or QYLD a better dividend investment in 2026?

CTIC currently yields 21.99% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: CTIC offers higher current income.

What is the dividend yield difference between CTIC and QYLD?

CTIC has a forward dividend yield of 21.99% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 10.07 percentage points.

Home › Compare › CTIC vs QYLD

CTIC vs QYLD: Dividend Comparison 2026

CTIC yields 21.99% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CTIC wins by $57.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CTIC

● Live price

21.99%

Share price

$9.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$82.4K

Annual income

$8,289.02

Full CTIC calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — CTIC vs QYLD

📍 CTIC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CTIC	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CTIC + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CTIC pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTIC

Annual income on $10K today (after 15% tax)

$1,869.16/yr

After 10yr DRIP, annual income (after tax)

$7,045.67/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, CTIC beats the other by $2,235.25/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTIC + QYLD for your $10,000?

CTIC: 50%QYLD: 50%

100% QYLD50/50100% CTIC

Portfolio after 10yr

$53.9K

Annual income

$6,974.17/yr

Blended yield

12.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CTIC right now

CTIC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$10.40

+14.3% upside vs current

Range: $9.00 — $13.00

Altman Z

-27.1

Piotroski

3/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTIC buys

QYLD buys

No recent congressional trades found for CTIC or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCTICQYLD

Forward yield	21.99% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$82.4K ✓	$25.4K
Annual income after 10y	$8,289.02 ✓	$5,659.31
Total dividends collected	$49.2K ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CTIC vs QYLD ($10,000, DRIP)

Year	CTIC Portfolio	CTIC Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$12,899	$2,199.01	$10,352	$1,192.36	+$2.5K → CTIC
2	$16,453	$2,650.94	$10,830	$1,347.57	+$5.6K → CTIC
3	$20,765	$3,160.11	$11,460	$1,539.07	+$9.3K → CTIC
4	$25,946	$3,727.36	$12,275	$1,777.84	+$13.7K → CTIC
5	$32,114	$4,352.67	$13,323	$2,078.95	+$18.8K → CTIC
6	$39,398	$5,035.11	$14,667	$2,463.34	+$24.7K → CTIC
7	$47,928	$5,772.90	$16,396	$2,960.57	+$31.5K → CTIC
8	$57,847	$6,563.46	$18,631	$3,612.97	+$39.2K → CTIC
9	$69,299	$7,403.48	$21,548	$4,482.15	+$47.8K → CTIC
10	$82,439	$8,289.02	$25,398	$5,659.31	+$57.0K → CTIC

CTIC vs QYLD: Complete Analysis 2026

CTIC — Stock

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

Full CTIC Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this CTIC vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTIC vs SCHD CTIC vs JEPI CTIC vs O CTIC vs KO CTIC vs MAIN CTIC vs XYLD CTIC vs JEPQ CTIC vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.